-Outlook The government today cleared the National Pharmaceutical Pricing Policy that will bring 348 Essential Drugs under price control, leading to reduction in prices. "The National Pharmaceutical Pricing policy has been approved by the Cabinet with an objective to put in place a regulatory framework for pricing of drugs to ensure their availability at reasonable prices," an official source said. At present, the government through the National Pharmaceutical Pricing Authority (NPPA) controls prices...

-The Economic Times MUMBAI: The ministerial panel entrusted with framing the country's drug pricing guidelines will meet Finance Minister P Chidambaram on Wednesday to discuss its final draft policy. The Group of Ministers, led by Agriculture Minister Sharad Pawar, has decided to keep the market-based pricing mechanism but tweak the methodology used for calculating the price increase, a move it hopes will address the concerns of the finance ministry. The ministry was initially...

-The Business Standard If the Cabinet clears the proposed policy, the Department of Pharmaceuticals would have to notify this before the SC?s next hearing on the matter on Nov 27 The Cabinet is likely to take up the proposed National Pharmaceutical Pricing Policy tomorrow, government sources said. The policy is aimed at capping the prices of 348 essential medicines at the weighted average of all drugs in a particular segment, with...

-The Business Standard The move is aimed at having a stringent regulatory system while bringing in uniformity in approach for pricing of drugs  The drug price regulator would now visit manufacturing facilities of pharmaceutical companies while fixing prices of essential medicines. The National Pharmaceutical Pricing Authority (NPPA) has issued internal guidelines putting in place norms for verification of actual cost data, provided by companies, through plant visits.  The move is aimed at...

-The Times of India Medicines in India may not be sold under brand names in the near future. In its biggest move to push generic drugs and do away with brand names, the Union health ministry has ordered states to stop issuing licence for the manufacture or sale of drugs on the basis of their brand name. All pharmaceutical firms applying for licence to market or manufacture fixed dose combination (FDC) drugs will...